MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer

BACKGROUND: Even though aberrant expression of microRNA (miR)-30d has been reported in prostate cancer (PCa), its associations with cancer progression remain contradictory. The aim of this study was to investigate clinical significance, biological functions and underlying mechanisms of miR-30d dereg...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Zhuo-yuan, Chen, Guo, Zhang, Yan-qiong, He, Hui-chan, Liang, Yu-xiang, Ye, Jian-heng, Liang, Ying-ke, Mo, Ru-jun, Lu, Jian-ming, Zhuo, Yang-jia, Zheng, Yu, Jiang, Fu-neng, Han, Zhao-dong, Wu, Shu-lin, Zhong, Wei-de, Wu, Chin-Lee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5327510/
https://www.ncbi.nlm.nih.gov/pubmed/28241827
http://dx.doi.org/10.1186/s12943-017-0615-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5327510/
https://www.ncbi.nlm.nih.gov/pubmed/28241827
http://dx.doi.org/10.1186/s12943-017-0615-x

Ejemplares similares